• Phone: +86 21 63862192
  • Mailbox: info@alphabiopharma.com
  • Shanghai: Unit 02-05, 11/F, East Tower, Raffles City The Bund No.1089 Dong Daming Road, Shanghai 200082, China
  • Beijing: Room 2512, The Place Tower, No. 9 Guanghua Road, Chaoyang District, Beijing

CSR
Corporate Social Responsibility

Since the beginning of 2020, while the whole country is actively fighting against the COVID-19 epidemic, the staff of Alpha Biopharma — a trusted innovative pharmaceutical company, has dedicated every effort for the safety, health and interests of patients and investigators of clinical trials.
Fight Against Viruses
Focus on Patients and Investigators

Focus on Patients and Investigators

The Alpha Biopharma always puts the safety of the patients and investigators as the top priority, based on which measures were carried out in the clinical trials during the outbreak. For patients who could not return to visit, we coordinated with the investigators actively to maintain the close contact with them by means of mobile phone, WeChat video call and so on.
Reasonably Arrange Visit and Strengthen Contact with Patients

Reasonably Arrange Visit and Strengthen Contact with Patients

The clinical operation team kept in touch with each site and coordinated with colleagues from medical science, pharmacovigilance, quality assurance as well as related responsible personnel from CRO/SMO, to conduct active discussion about the different types of visit arrangement, safe and rational drug use and more frequent dialogues between patients and sites. All the investigators worked together to develop action plans, ensuring patients' medication safety and promoting rational drug use.

Reasonably Arrange Visit and Strengthen Contact with Patients
Actively Ensure Drug Supply for Clinical Trials

Actively Ensure Drug Supply for Clinical Trials

Around January 20th, 2020, even before the COVID-19 epidemic, the project team had already reached the front-line personnel (CRC/CRA) in clinical trials and communicated with hospitals/investigators, pharmacies and other healthcare workers actively to ensure the efficiency of drug supply.
Focus on Safety Protection for Front-line CRC/CRA

Focus on Safety Protection for Front-line CRC/CRA

Alpha Biopharma guaranteed patients of their normal treatment and clinical trial quality during the outbreak. In addition, we were very concerned about the protection of the related personnel (CRC/CRA) who carried out clinical trials on the front line. We purchased a certain number of medical masks, hand sanitizers, effervescent tablets, goggles, protective clothing and other resources (a total of 3,000 sets) through different channels, and sent them to 41 sites involved in the clinical trials across China as soon as possible to ensure the smooth daily work of each front-line staff.

Focus on Safety Protection for Front-line CRC/CRA